← All instruments
Dividend per share. FY26 is in progress: that bar shows what has been declared so far, not a full year.
Lincoln Pharmaceuticals Limited
StockNSE: LINCOLN· Face value ₹10
₹581.40
▲ 0.34%
Delayed · as of 29 Jul 2026
Dividend per share by financial year
| Financial year | Total dividend |
|---|---|
| FY02 | ₹0.80 |
| FY08 | ₹0.24 |
| FY09 | ₹0.24 |
| FY10 | ₹1.20 |
| FY11 | ₹1.20 |
| FY12 | ₹0.60 |
| FY13 | ₹0.60 |
| FY14 | ₹0.60 |
| FY15 | ₹0.60 |
| FY16 | ₹1.00 |
| FY17 | ₹1.00 |
| FY18 | ₹1.20 |
| FY19 | ₹1.50 |
| FY20 | ₹3.00 |
| FY22 | ₹1.50 |
| FY23 | ₹1.50 |
| FY24 | ₹1.50 |
| FY25 | ₹1.80 |
| FY26 | ₹1.80 |
Dividend history
Source: NSE & BSE announcementsDownload CSV| Type | Amount | Ex-date | Record date | Payment date | FY | Confirmed by |
|---|---|---|---|---|---|---|
| FINAL | ₹1.80 | 12 Sept 2025 | 12 Sept 2025 | — | FY26 | BSE + NSE |
| FINAL | ₹1.80 | 13 Sept 2024 | — | — | FY25 | BSE + NSE |
| FINAL | ₹1.50 | 15 Sept 2023 | — | — | FY24 | BSE + NSE |
| FINAL | ₹1.50 | 15 Sept 2022 | — | — | FY23 | BSE + NSE |
| FINAL | ₹1.50 | 16 Sept 2021 | — | — | FY22 | BSE + NSE |
| INTERIM | ₹1.50 | 05 Mar 2020 | 06 Mar 2020 | — | FY20 | BSE + NSE |
| FINAL | ₹1.50 | 19 Sept 2019 | — | — | FY20 | BSE + NSE |
| FINAL | ₹1.50 | 19 Sept 2018 | — | — | FY19 | BSE + NSE |
| FINAL | ₹1.20 | 21 Sept 2017 | — | — | FY18 | BSE + NSE |
| FINAL | ₹1.00 | 23 Sept 2016 | — | — | FY17 | BSE + NSE |
| FINAL | ₹1.00 | 23 Sept 2015 | — | — | FY16 | BSE |
| FINAL | ₹0.60 | 25 Sept 2014 | — | — | FY15 | BSE |
| FINAL | ₹0.60 | 19 Sept 2013 | — | — | FY14 | BSE |
| FINAL | ₹0.60 | 20 Sept 2012 | — | — | FY13 | BSE |
| FINAL | ₹0.60 | 22 Sept 2011 | — | — | FY12 | BSE |
| FINAL | ₹1.20 | 23 Sept 2010 | — | — | FY11 | BSE |
| FINAL | ₹1.20 | 17 Sept 2009 | — | — | FY10 | BSE |
| FINAL | ₹0.24 | 18 Sept 2008 | — | — | FY09 | BSE |
| FINAL | ₹0.24 | 20 Sept 2007 | — | — | FY08 | BSE |
| FINAL | ₹0.80 | 11 Sept 2001 | — | — | FY02 | BSE |